Undesirable financial effects of head and neck cancer radiotherapy during the initial treatment period

References

• Wissinger E, Griebsch I, Lungershausen J, Foster T, Pashos CL. The economic burden of head and neck cancer: a systematic literature review. Pharmacoeconomics. 2014; 32: 865–82. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Gold KA, Lee HY, Kim ES. Targeted therapies in squamous cell carcinoma of the head and neck. Cancer. 2009; 115: 922–35. [PubMed Abstract].
   Google Scholar
• Crombie AK, Farah CS, Batstone MD. Health-related quality of life of patients treated with primary chemoradiotherapy for oral cavity squamous cell carcinoma: a comparison with surgery. Br J Oral Maxillofac Surg. 2014; 52: 111–17. [PubMed Abstract].
   Google Scholar
• Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, etal. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013; 18: 381–90. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Arozullah AM, Calhoun EA, Wolf M, Finley DK, Fitzner KA, Heckinger EA, etal. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. 2004; 2: 271–8. [PubMed Abstract].
   Google Scholar
• Chang S, Long SR, Kutikova L, Bowman L, Finley D, Crown WH, etal. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 and 2000. J Clin Oncol. 2004; 22: 3524–30. [PubMed Abstract].
   Google Scholar
• Bradley CJ, Neumark D, Luo Z, Schenk M. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Canc Investig. 2007; 25: 47–54.
   PubMed Web of Science ®Google Scholar
• Allirajah D, Herbst K, Morgan L. Free at the point of delivery? Exposing the hidden cost of hospital travel and parking for cancer patients. A Macmillan Cancer Relief report in association with Dr Foster Ltd. 2005; London: Macmillan Center.
   Google Scholar
• Lauzier S, Maunsell E, De Kroninck M, Drolet M, Hèbert-Croteau N, Robert J. Conceptualization and sources of costs from breast cancer: findings from patient and caregiver focus groups. Psycho Oncol. 2005; 14: 351–60.
   Web of Science ®Google Scholar
• Timmons A, Gooberman-Hill R, Sharp L. The multidimensional nature of the financial and economic burden of a cancer diagnosis on patients and their families: qualitative findings from a country with a mixed public-private healthcare system. Support Care Canc. 2013; 21: 107–17.
   PubMed Web of Science ®Google Scholar
• Egestad H, Nieder C. Differences in quality of life in obese and normal weight head and neck cancer patients undergoing radiation therapy. Support Care Cancer. 2014
   Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez J, etal. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials on oncology. J Natl Canc Inst. 1993; 85: 365–76.
   PubMed Web of Science ®Google Scholar
• Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, etal. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. Eur J Canc. 2000; 36: 1796–807.
   PubMed Web of Science ®Google Scholar
• Borggreven PA, Verdonck-de Leeuw IM, Muller M, Heiligers LCH, de Bree R, Aaronson NK, etal. Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective study. Eur Arch Otorhinolaryngol. 2007; 264: 651–7. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen JF, etal. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol. 1999; 17: 1008–19. [PubMed Abstract].
   Google Scholar
• Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, etal. The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer. 1995; 31A: 2260–3. [PubMed Abstract].
   Google Scholar
• Bjordal K, Ahlner-Elmqvist M, Hammerlid E, Boysen M, Evensen JF, Björklund A, etal. A prospective study of quality of life in head and neck cancer patients. Part II: longitudinal data. Laryngoscope. 2001; 111: 1440–52. [PubMed Abstract].
   Google Scholar
• Bentzen AG, Balteskard L, Wanderås EH, Frykholm G, Wilsgaard T, Dahl O, etal. Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors. Acta Oncol. 2013; 52: 736–44. [PubMed Abstract].
   Google Scholar
• Hinz A, Singer S, Brähler E. European reference values for the quality of life questionnaire EORTC QLQ-C30: results of a German investigation and a summarizing analysis of six European general population normative studies. Acta Oncol. 2014; 53: 958–65. [PubMed Abstract].
   Google Scholar
• Curran D, Giralt J, Harari PM, Ang KK, Cohen B, Kies MS, etal. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol. 2007; 25: 2191–7. [PubMed Abstract].
   Google Scholar
• Airoldi M, Corstesina G, Giordano C, Pedani F, Gabriele AM, Marchionatti S, etal. Postoperative adjuvant chemoradiotherapy in older patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004; 130: 161–6. [PubMed Abstract].
   Google Scholar
• Braam PM, Roesink JM, Raaijmakers CP, Busschers WB, Terhaard C. Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy. Radiat Oncol. 2007; 2: 3. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ackerstaff A, Rasch CR, Balm JM, de Boer JP, Wiggenraad R, Rietveld DH, etal. Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer. Head Neck. 2012; 34: 974–80. [PubMed Abstract].
   Google Scholar
• Shepherd KL, Fisher SE. Prospective evaluation of quality of life in patients with oral and oropharyngeal cancer: from diagnosis to three mouths post-treatment. Oral Oncol. 2004; 40: 751–7. [PubMed Abstract].
   Google Scholar
• Magnussen J, Vrangbæk K, Saltman R. Nordic health care systems: recent reforms and current policy challenges. 2009; London: Open University Press.
   Google Scholar
• Syse A, Tønnessen M. Cancer's unequal impact on incomes in Norway. Acta Oncol. 2012; 51: 480–9. [PubMed Abstract].
   Google Scholar
• Kalseth J, Halvorsen T, Kalseth B, Anthun KS, Peltola M, Kautiainen K, etal. Cross-country comparisons of health-care costs: the case of cancer treatment in the Nordic countries. Health Policy. 2014; 115: 172–9. [PubMed Abstract].
   Google Scholar
• Wong YN, Egleston BL, Sachdeva K, Eghan N, Pirollo M, Stump TK, etal. Cancer patients’ trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative setting. Med Care. 2013; 51: 838–45. [PubMed Abstract] Erratum in Med Care. 2013;51:1029.
   Google Scholar
• Šaltytė Benth J, Dahl FA, Lurås H, Dahl AA. A controlled study of income development for breast cancer survivors in Norway. J Cancer Surviv. 2014; 8: 239–47.
   PubMed Web of Science ®Google Scholar
• Ghaderi S, Engeland A, Moster D, Ruud E, Syse A, Wesenberg F, etal. Increased uptake of social security benefits among long-term survivors of cancer in childhood, adolescence and young adulthood: a Norwegian population-based cohort study. Br J Cancer. 2013; 108: 1525–33. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar